Skip to content
★ Sign in to follow
GI

Genspera Inc Stock: price and insider trades · United States

Genspera Inc: what insiders have been doing

Only a handful of insider records exist for Genspera Inc, the last one from 3 November 2015, too few to describe a trend. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Insider Decl.
6
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a

Financial data

as of FY 2022

FY ended December 2022 · cache

Income statement
Net income-910.4k
Last declaration on 3 November 2015
Declarations6 total
  • ●
    CEO, CFO, PresidentExecutives
    105,000 USD0SEC
    262,500 shares@ US$0.40Common StockSEC:0001144204-15-062579:0
  • ●
    CEO, CFO, PresidentExecutives
    0SEC
    415,738 shares0Common StockSEC:0001144204-15-058987:0
  • ●
    CEO, CFO, PresidentExecutives
    0SEC
    1,000,000 shares0Common StockSEC:0001144204-15-058987:1
  • ●
    CEO, CFO, PresidentExecutives
    0SEC
    415,738 shares0Common StockSEC:0001144204-15-058987:2
  • ●
    CEO, CFO, PresidentExecutives
    0SEC
    500,000 shares0Common StockSEC:0001144204-15-058987:3
  • ●
    CEO, CFO, PresidentExecutives
    0SEC
    500,000 shares0Common StockSEC:0001144204-15-058987:4

6 of 6 declarations

About Genspera Inc

Genspera Inc is a company listed on the XNAS market, focused on developing innovative therapies for cancer treatment. It concentrates on biotechnology-based approaches to enhance patient outcomes.